Literature DB >> 2878761

COPD: causes, treatment, and risk for lung cancer.

D M Skillrud.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878761

Source DB:  PubMed          Journal:  Compr Ther        ISSN: 0098-8243


× No keyword cloud information.
  5 in total

1.  Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.

Authors:  G Hodge; J Barnawi; C Jurisevic; D Moffat; M Holmes; P N Reynolds; H Jersmann; S Hodge
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 2.  Previous lung diseases and lung cancer risk: a systematic review and meta-analysis.

Authors:  Darren R Brenner; John R McLaughlin; Rayjean J Hung
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

3.  Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study.

Authors:  Ajn Raymakers; D D Sin; M Sadatsafavi; J M FitzGerald; C A Marra; L D Lynd
Journal:  Respir Res       Date:  2020-05-19

4.  Inhalation exposure to cigarette smoke and inflammatory agents induces epigenetic changes in the lung.

Authors:  Christopher L Seiler; J Ung Min Song; Delshanee Kotandeniya; Jianji Chen; Thomas J Y Kono; Qiyuan Han; Mathia Colwell; Benjamin Auch; Aaron L Sarver; Pramod Upadhyaya; Yanan Ren; Christopher Faulk; Silvio De Flora; Sebastiano La Maestra; Yue Chen; Fekadu Kassie; Natalia Y Tretyakova
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

5.  Defective lung macrophage function in lung cancer ± chronic obstructive pulmonary disease (COPD/emphysema)-mediated by cancer cell production of PGE2?

Authors:  Francis C Dehle; Violet R Mukaro; Craig Jurisevic; David Moffat; Jessica Ahern; Greg Hodge; Hubertus Jersmann; Paul N Reynolds; Sandra Hodge
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.